Onkure Therapeutics - Class A (OKUR) closed at $2.30 on October 21, 2026, down 2.5% from the previous close, on volume of 228,654 shares (30-day average 356,788).
Data as of October 21, 2026.
No headlines found.
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
Globe Newswire (Mon, 31-Aug 8:00 AM ET)
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Globe Newswire (Tue, 4-Aug 4:05 PM ET)
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Ka. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.
As of October 21, 2026, OKUR stock price declined to $2.30 with 228,654 million shares trading.
OKUR has a beta of 1.43, meaning it tends to be more sensitive to market movements. OKUR has a correlation of 0.06 to the broad based SPY ETF.
OKUR has a market cap of $93.14 million. This is considered a Micro Cap stock.
Last quarter Onkure Therapeutics - Class A reported $0 in Revenue and -$.31 earnings per share. This fell short of revenue expectation by $-200,000 and exceeded earnings estimates by $.31.
The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
OKUR has underperformed the market in the last year with a price return of -21.5% while the SPY ETF gained +16.3%. OKUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -44.2% and -6.5%, respectively, while the SPY returned +4.4% and -0.8%, respectively.
OKUR support price is $2.23 and resistance is $2.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.
